Literature DB >> 6365207

Outcome of bone marrow transplantation in patients with extramedullary involvement of acute leukemia.

W E Spruce, S J Forman, R A Krance, M J Farbstein, J L Wolf, E P Scott, A P Nademanee, J L Fahey, M Henke, K G Blume.   

Abstract

Infiltration of extrahemopoietic tissue with leukemic cells was evaluated as a prognostic indicator in 18 patients with acute leukemia undergoing bone marrow transplantation. When compared to 107 patients who did not have extramedullary leukemia at any time prior to marrow grafting, the patients with leukemic invasion into organs outside the hemopoietic system had a significant increase of leukemic recurrence and a significant decrease in survival after marrow transplantation. Extramedullary leukemia may be a negative prognostic indicator for bone marrow transplantation candidates.

Entities:  

Mesh：

Year:  1984        PMID： 6365207     DOI： 10.1007/bf00320033

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


  10 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

2.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

Authors:  E D Thomas; C D Buckner; R A Clift; A Fefer; F L Johnson; P E Neiman; G E Sale; J E Sanders; J W Singer; H Shulman; R Storb; P L Weiden
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

3.  Marrow transplantation for patients with acute lymphoblastic leukemia in remission.

Authors:  E D Thomas; J E Sanders; N Flournoy; F L Johnson; C D Buckner; R A Clift; A Fefer; B W Goodell; R Storb; P L Weiden
Journal:  Blood       Date:  1979-08       Impact factor: 22.113

4.  Relapse following marrow transplantation for acute leukemia.

Authors:  D T Harrison; N Flournoy; R Ramberg; C Boyd; K Erne; C D Buckner; A Fefer; J E Sanders; R Storb; E D Thomas
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

5.  Allogeneic marrow transplantation for patients with acute leukemia.

Authors:  C D Buckner
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

6.  Bone marrow ablation and marrow transplantation in acute leukemia: influence of clinical pretransplant condition.

Authors:  K G Blume; W E Spruce; S J Forman; K J Bross; E Beutler; M J Farbstein; J L Fahey; G M Schmidt; E P Scott; J L Wolf
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

7.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

8.  Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.

Authors:  K G Blume; E Beutler; K J Bross; R K Chillar; O B Ellington; J L Fahey; M J Farbstein; S J Forman; G M Schmidt; E P Scott; W E Spruce; M A Turner; J L Wolf
Journal:  N Engl J Med       Date:  1980-05-08       Impact factor: 91.245

9.  The place of bone-marrow transplantation in acute myelogenous leukaemia.

Authors:  R L Powles; G Morgenstern; H M Clink; D Hedley; G Bandini; H Lumley; J G Watson; D Lawson; D Spence; A Barrett; B Jameson; S Lawler; H E Kay; T J McElwain
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

10.  A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission.

Authors:  F L Johnson; E D Thomas; B S Clark; R L Chard; J R Hartmann; R Storb
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.